GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

101 hedge funds and large institutions have $754M invested in Genomic Health, Inc. in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

53% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 30

78% less call options, than puts

Call options by funds: $2.1M | Put options by funds: $9.61M

Holders
101
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.1M
Puts
$9.61M
Net Calls
Net Calls Change

Top Sellers

1 -$27M
2 -$3.54M
3 -$3.19M
4
Goldman Sachs
Goldman Sachs
New York
-$2.75M
5
Morgan Stanley
Morgan Stanley
New York
-$2.2M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$165K
77
$111K
78
$97K
79
$86K
80
$69K
81
$58K
82
$37K
83
$31K
84
$26K
85
$26K
86
$23K
87
$16K
88
$15K
89
$11K
90
$10.7K
91
$8K
92
$8K
93
$8K
94
$7K
95
$5K
96
$5K
97
$5K
98
$5K
99
$4K
100
$3K